Delivery Order SPE2DR25D3101-SPE2DR26F6A46
- Not listed
- The Defense Logistics Agency awarded a $5,473.29 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector units, with a completion date of December 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol, representing the type of specialized pharmaceutical product that...
- The Defense Logistics Agency awarded a $33,600.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of January 21, 2026. This competitive award with no set-aside designation represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The contract...
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $3,095.48 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 27, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a $15,982.03 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors under a firm fixed-price contract. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, represents a non-set-aside competitive procurement. This delivery order is a child contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $11,276.07 to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injectors. This firm fixed-price, competitively awarded contract (No. 4570376219) is scheduled for completion by December 31, 2025, with the award issued on December 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $36,642.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 28, 2026, with an ultimate completion date of January 29, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. REPATHA is a PCSK9 inhibitor used to treat high cholesterol and reduce cardiovascular risk in patients with...
- The Defense Logistics Agency awarded a delivery order valued at $38,482.24 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of January 16, 2026. This competitive award utilizes firm fixed-price pricing with no set-aside designation, and performance will be executed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F6A46Delivery Order
The Defense Logistics Agency awarded a $4,430.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, with an ultimate completion date of January 29, 2026, represents a child order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used in the treatment of high cholesterol and cardiovascular disease management. AmerisourceBergen Drug Corp serves as a critical pharmaceutical vendor within the federal medical supply chain, consistently delivering brand-name and generic medications, vaccines, and specialized medical supplies to military healthcare systems and other government agencies. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements across multiple therapeutic domains. This delivery order exemplifies the routine pharmaceutical supply operations conducted under the DLA Troop Support Medical prime vendor agreement, enabling the company to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with essential medications required for military medical facilities and veteran care programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/27/26 |